Clinical management of spasticity.
Thompson
A J
AJ
Jarrett
L
L
Lockley
L
L
Marsden
J
J
Stevenson
V L
VL
D000465:Algorithms; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000150:complications / Q000473:pathology / Q000628:therapy*; D004599:Electric Stimulation Therapy / Q000379:methods; D005242:Fecal Incontinence / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D009046:Motor Neurons / Q000473:pathology; D009069:Movement Disorders / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D009433:Neural Inhibition / Q000502:physiology; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010348:Patient Care Team; D026741:Physical Therapy Modalities; D012720:Severity of Illness Index; D001745:Urinary Bladder Diseases / Q000209:etiology / Q000503:physiopathology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A